Ulipristal Acetate vs Gonadotropin-Releasing Hormone Agonists Prior to Laparoscopic Myomectomy (MYOMEX Trial): Short-term Results of a Double-blind Randomized Controlled Trial
Year: 2019
Type: article
Abstract: (Abstracted from Acta Obstet Gynecol Scand 2019; doi: 10.1111/aogs.13713) Two agents used for pretreatment of fibroids before myomectomy are gonadotropin-releasing hormone agonists (GnRHa)—considered a criterion standard—and ulipristal acetate (UPA), a selective progesterone receptor modulator (SPRM) recently approved for preoperative treatment. No randomized trials have compared pretreatment of uterine fibroids with GnRHa or UPA prior to laparoscopic myomectomy.
Institutions: Maastricht University Medical Centre, Catharina Ziekenhuis, Amsterdam UMC Location University of Amsterdam, Maastricht University, OLVG, Máxima Medisch Centrum, Amsterdam University Medical Centers, Spaarne Gasthuis, Amsterdam Reproduction Development, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2996123791
